These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1401624)

  • 41. Interaction of acute ventricular dilatation and d-sotalol during sustained reentrant ventricular tachycardia around a fixed obstacle.
    Reiter MJ; Zetelaki Z; Kirchhof CJ; Boersma L; Allessie MA
    Circulation; 1994 Jan; 89(1):423-31. PubMed ID: 7506639
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of the signal-averaged ECG to predict maximum ventricular tachycardia rate.
    Tyson AA; Edwards RR; Matista JF; Mumma M; Haisty WK
    J Electrocardiol; 1990; 23 Suppl():164-8. PubMed ID: 2090737
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Repolarization changes in a double-blind crossover study of dofetilide versus sotalol in the treatment of ventricular tachycardia.
    Boriani G; Biffi M; De Simone N; Bacchi L; Martignani C; Bitonti F; Zannoli R; Butrous G; Branzi A
    Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1935-8. PubMed ID: 11139961
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of signal averaging of the surface QRS complex in selecting patients with nonsustained ventricular tachycardia and high grade ventricular arrhythmias for programmed ventricular stimulation.
    Winters SL; Stewart D; Targonski A; Gomes JA
    J Am Coll Cardiol; 1988 Dec; 12(6):1481-7. PubMed ID: 3192846
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of class I drugs on the cycle length of sustained ventricular tachycardia and the signal-averaged electrocardiogram.
    Doi T; Inoue T; Ohnishi Y; Yokoyama M
    Jpn Circ J; 1997 Jun; 61(6):495-502. PubMed ID: 9225195
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The signal-averaged electrocardiogram as a screening test for inducibility of sustained ventricular tachycardia in high risk patients: a prospective study.
    Nalos PC; Gang ES; Mandel WJ; Ladenheim ML; Lass Y; Peter T
    J Am Coll Cardiol; 1987 Mar; 9(3):539-48. PubMed ID: 3819201
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of signal-averaged electrocardiography for predicting inducible sustained monomorphic ventricular tachycardia in patients with bundle branch block with and without a history of syncope.
    Englund A; Rosenqvist M; Bergfeldt L
    Am Heart J; 1995 Sep; 130(3 Pt 1):481-8. PubMed ID: 7661064
    [TBL] [Abstract][Full Text] [Related]  

  • 48. d-Sotalol decreases defibrillation energy requirements in humans: a novel indication for drug therapy.
    Dorian P; Newman D; Sheahan R; Tang A; Green M; Mitchell J
    J Cardiovasc Electrophysiol; 1996 Oct; 7(10):952-61. PubMed ID: 8894937
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term efficacy of d/l sotalol in patients with sustained ventricular tachycardia refractory to class I antiarrhythmic drugs.
    Kühlkamp V; Mermi J; Mewis C; Braun U; Seipel L
    Eur Heart J; 1995 Nov; 16(11):1625-31. PubMed ID: 8881857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of sotalol on RR interval variability during induced ventricular tachycardia.
    Yli-Mäyry S; García-Alberola A; Haverkamp W; Hindricks G; Martínez-Rubio A; Borggrefe M; Breithardt G
    Am J Cardiol; 1996 Aug; 78(3):372-6. PubMed ID: 8759826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Failure of signal-averaged electrocardiography with use of time-domain variables to predict inducible ventricular tachycardia in patients with conduction defects.
    Ommen SR; Hammill SC; Bailey KR
    Mayo Clin Proc; 1995 Feb; 70(2):132-6. PubMed ID: 7845038
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Electrophysiologic effects of intravenous and oral sotalol for sustained ventricular tachycardia secondary to coronary artery disease.
    Kopelman HA; Woosley RL; Lee JT; Roden DM; Echt DS
    Am J Cardiol; 1988 May; 61(13):1006-11. PubMed ID: 3284316
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Right bundle branch block, intermittent ST segment elevation and inducible ventricular tachycardia in an asymptomatic patient: an unusual presentation of the Brugada syndrome?
    Bertaglia E; Michieletto M; Spedicato L; Pascotto P
    G Ital Cardiol; 1998 Aug; 28(8):893-8. PubMed ID: 9773315
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of intravenous amiodarone on ventricular refractoriness, intraventricular conduction, and ventricular tachycardia induction.
    Kułakowski P; Karczmarewicz S; Karpiński G; Soszyńska M; Ceremuzyński L
    Europace; 2000 Jul; 2(3):207-15. PubMed ID: 11227590
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Signal averaged ECG and mechanisms of sudden death].
    Brembilla-Perrot B; Terrier de la Chaise A
    Arch Mal Coeur Vaiss; 1990 Nov; 83(12):1801-7. PubMed ID: 2125190
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk stratification of patients with complex ventricular arrhythmias. Value of ambulatory electrocardiographic recording, programmed electrical stimulation and the signal-averaged electrocardiogram.
    el-Sherif N; Turitto G; Fontaine JM
    Herz; 1988 Jun; 13(3):204-14. PubMed ID: 2456972
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predicting the effect of D,L-sotalol on ventricular tachycardia inducibility from the RR variability response.
    Brembilla-Perrot B; Houriez P; Claudon O; Preiss JP; Beurrier D
    Heart; 1999 Sep; 82(3):307-11. PubMed ID: 10455080
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multiple monomorphic ventricular tachycardia configurations predict failure of antiarrhythmic drug therapy guided by electrophysiologic study.
    Mitrani RD; Biblo LA; Carlson MD; Gatzoylis KA; Henthorn RW; Waldo AL
    J Am Coll Cardiol; 1993 Oct; 22(4):1117-22. PubMed ID: 8409050
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Usefulness of QRS prolongation in predicting risk of inducible monomorphic ventricular tachycardia in patients referred for electrophysiologic studies.
    Horwich T; Lee SJ; Saxon L
    Am J Cardiol; 2003 Oct; 92(7):804-9. PubMed ID: 14516880
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative electrophysiologic findings between responders and nonresponders to class III antiarrhythmic drugs among patients with ventricular tachyarrhythmia.
    Naitoh N; Washizuka T; Takahashi K; Miyajima T; Aizawa Y
    Jpn Heart J; 1998 May; 39(3):307-19. PubMed ID: 9711182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.